4Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction [ J ]. Circulation ,2000,102 ( 25 ) :3039 - 3045.
5Hedlund J, Christenson B, Lundbergh P, et al. Effects of a large - scale intervention with influenza and 23 - valent pneumococcal vaccines in elderly people : a 1 - year follow - up [ J ]. Vaccine, 2003,21 ( 25 -26) :3906 - 3911.
6Yap FH, Ho PL, Lam KF, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong [ J ]. J Med virol, 2004,73 ( 4 ) : 617 - 623.
7Nichol KL, Wuorenma J, yon Stemberg T. Benefits of influenza vaccination for low - , intermediate - , and high -risk senior citizens [ J ] , Arch Intern Med, 1998,158 (16) : 1769 - 1776.
8Centers for Disease Control and Prevention. Influenza and pnueumococol vaccination levels among adults ageed > 65 In United States, 1997 [ J ]. MMWR, 1998,47 (38) :797 - 803.
9Beyer WE, Palache AM, de Jong JC, et al. Cold - adapted live influenza vaccine versus inactivated vaccine : systemic vaccine reactions, local and systemic antibody response, and vaccine, 2002, 20 ( 9 - 10 ) : 1340 - 1353.
10Cox R J, Brokstad KA, Ogra P. Influenza virus : immunity and vaccination strategies, Comparison of the immune response to inactivated and live, attenuated influenza vaccines [ J ]. Scand J Immunol, 2004, 59 (1):1 -15.
5Angela, Domtnguez,Jesfis, et al. Benefit of conjugate pneumococ- cal vaccination in preventing influenza hospitalization in children: a case-contrel study[ J]. The Pediatric infectious disease journal, 2013,32(g) :330 -4.
